Mutual Funds that own hVIVO PLC
CF Woodford Equity Income
15,635,064
19.73%
0
0.16%
07/31/2018
Invesco Perpetual UK Invt. Ser. - High Income
13,309,222
16.8%
0
0.09%
03/29/2018
Invesco Perpetual UK 2 Invt. Series - Income Fund
7,940,160
10.02%
0
0.11%
03/29/2018
Asperior Investment Funds - CF Ruffer Absolute Return Fund
1,484,449
1.87%
0
0.02%
09/29/2017
935,136
1.18%
0
0.45%
12/31/2017
Henderson Opportunities Trust Plc
844,645
1.07%
0
0.42%
12/31/2017
Edinburgh Worldwide Investment Trust Plc
768,899
0.97%
0
0.1%
10/31/2017
Artemis Alpha Trust Plc
680,002
0.86%
314
0.24%
10/31/2017
Baillie Gifford Overseas Growth Fund - Global Discovery Fund
553,717
0.7%
0
0.07%
04/30/2018
Sandaire Generation Fund
327,210
0.41%
0
0.23%
12/31/2017
| Address |
Queen Mary BioEnte Innovation Centre
London London & South East E1 2AX
United Kingdom
|
|
Employees
|
- |
| Website |
http://retroscreen.com |
| Updated |
07/08/2019 |
| hVIVO Plc is an investment holding company, which engages in the provision of human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. It focuses on medical and scientific research services. The company was founded by John Sidney Oxford on March 27, 2012 and is headquartered in London, the United Kingdom. |
